GSK PLC (NYSE:GSK)
$ 34.08 -0.04 (-0.12%) Market Cap: 69.61 Bil Enterprise Value: 84.95 Bil PE Ratio: 21.96 PB Ratio: 3.90 GF Score: 71/100

Q4 2019 GlaxoSmithKline PLC Earnings Call Transcript

Feb 05, 2020 / 02:00PM GMT
Release Date Price: $46.34 (-4.35%)
Operator

Good afternoon, ladies and gentlemen. And welcome to the Analyst Call on the GSK Fourth Quarter 2019 Results. I will now hand you over to Sarah Elton-Farr, Head of Investor Relations, who will introduce today's session.

Sarah Elton;Farr
GlaxoSmithKline plc - Head of IR

Thank you. Good morning and good afternoon. Thank you for joining us for our full year 2019 results, which were issued earlier today. You should have received our press release and can view the presentation on GSK's website. For those not able to view the webcast, slides that accompany today's call are located on the Investors section of the GSK website.

Before we begin, please refer to Slide 2 of our presentation for our cautionary statements. Our speakers today are Chief Executive Officer, Emma Walmsley; Iain Mackay, Chief Financial Officer; and Dr. Hal Barron, Chief Scientific Officer and President of R&D; and we have a broader team for Q&A. (Operator Instructions)

Our presentation will last for approximately 45 minutes, slightly longer than usual,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot